Positive News SentimentPositive NewsNASDAQ:EDSA Edesa Biotech (EDSA) Stock Price, News & Analysis $5.42 +0.31 (+6.07%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$5.23▼$5.5950-Day Range$4.15▼$5.4252-Week Range$2.46▼$8.33Volume10,436 shsAverage Volume7,022 shsMarket Capitalization$17.45 millionP/E RatioN/ADividend YieldN/APrice Target$39.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get Edesa Biotech alerts: Email Address Edesa Biotech MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside619.6% Upside$39.00 Price TargetShort InterestHealthy0.82% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($2.19) to ($1.75) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.03 out of 5 starsMedical Sector405th out of 936 stocksPharmaceutical Preparations Industry188th out of 436 stocks 3.5 Analyst's Opinion Consensus RatingEdesa Biotech has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageEdesa Biotech has only been the subject of 1 research reports in the past 90 days.Read more about Edesa Biotech's stock forecast and price target. Previous Next 4.0 Short Interest Percentage of Shares Shorted0.82% of the float of Edesa Biotech has been sold short.Short Interest Ratio / Days to CoverEdesa Biotech has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Edesa Biotech has recently decreased by 0.56%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldEdesa Biotech does not currently pay a dividend.Dividend GrowthEdesa Biotech does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for EDSA. Previous Next 3.3 News and Social Media Coverage News SentimentEdesa Biotech has a news sentiment score of 1.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Edesa Biotech this week, compared to 0 articles on an average week. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Edesa Biotech insiders have not sold or bought any company stock.Percentage Held by Insiders25.00% of the stock of Edesa Biotech is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 5.50% of the stock of Edesa Biotech is held by institutions.Read more about Edesa Biotech's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Edesa Biotech are expected to grow in the coming year, from ($2.19) to ($1.75) per share.Price to Book Value per Share RatioEdesa Biotech has a P/B Ratio of 2.32. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Edesa Biotech's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad True Market InsidersAmazon coin set to soar 25X – starting August 19thChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…Click For My #1 FREE Crypto for 2024 About Edesa Biotech Stock (NASDAQ:EDSA)Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in Covid-19 patients; and EB01, a topical vanishing cream containing non-steroidal anti-inflammatory compound that has completed Phase 2b clinical study to treat chronic allergic contact dermatitis. The company also develops EB02, an extension of secretory phospholipase 2 anti-inflammatory cream for treating erythema, swelling, and exudation associated with hemorrhoids disease; and EB06, an anti- chemokine ligand 10 (CXCL10) monoclonal antibody in vitiligo. It has a collaboration agreement with NovImmune SA to develop monoclonal antibodies targeting products containing toll-like receptor 4 and CXCL10 for therapeutic, prophylactic, and diagnostic applications in humans and animals; and Yissum Research Development Company for the development of products for therapeutic, prophylactic, and diagnostic uses in topical dermal and anorectal applications, as well as for the use in dermatologic and gastrointestinal conditions. The company was founded in 2015 and is headquartered in Markham, Canada.Read More EDSA Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart EDSA Stock News HeadlinesMay 28, 2024 | finance.yahoo.comEDSA: Preparing IND for Phase 2 Trial of EB06 in VitiligoMay 10, 2024 | investorplace.comEDSA Stock Earnings: Edesa Biotech Beats EPS for Q2 2024July 27, 2024 | The Oxford Club (Ad)Alex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time to watch it.February 15, 2024 | finance.yahoo.comEDSA: Development of EB05 in ARDS Continues…February 14, 2024 | investing.comEdesa Biotech Inc (EDSA)February 11, 2024 | benzinga.comEdesa Biotech Stock (NASDAQ:EDSA) Earnings Dates and Earning CallsFebruary 9, 2024 | finance.yahoo.comEdesa Biotech Reports Fiscal 1st Quarter 2024 ResultsJanuary 2, 2024 | finance.yahoo.comEDSA: Updated Phase 3 Protocol for EB05 Trial Approved by Canadian Regulators…July 27, 2024 | The Oxford Club (Ad)Alex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time to watch it.December 15, 2023 | finance.yahoo.comEdesa Biotech Reports Fiscal Year 2023 ResultsDecember 1, 2023 | benzinga.comEdesa Biotech Stock (NASDAQ:EDSA) Dividends: History, Yield and DatesNovember 12, 2023 | morningstar.comEdesa Biotech Inc EDSANovember 2, 2023 | msn.comEdesa Biotech (EDSA) Price Target Increased by 528.00% to 53.38October 26, 2023 | finance.yahoo.comEdesa Biotech to Present at Dermatology Drug Development SummitOctober 25, 2023 | finance.yahoo.comRegulators Approve Updated Phase 3 Trial Design for Edesa Biotech’s ARDS DrugOctober 19, 2023 | finance.yahoo.comEDSA: Secures up to CAD$23 Million to Fund Development of EB05…October 12, 2023 | msn.comWhy Is Infectious Disease Player Edesa Biotech Stock Soaring Today?October 12, 2023 | finance.yahoo.comEdesa Biotech to Receive Up To C$23 Million in Funding from Federal GovernmentSee More Headlines Receive EDSA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Edesa Biotech and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/10/2024Today7/27/2024Next Earnings (Estimated)8/14/2024Fiscal Year End9/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:EDSA CUSIPN/A CIK1540159 Webwww.edesabiotech.com Phone(289) 800-9600Fax805-488-2889Employees20Year FoundedN/APrice Target and Rating Average Stock Price Target$39.00 High Stock Price Target$57.00 Low Stock Price Target$21.00 Potential Upside/Downside+619.6%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-8,370,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-115.59% Return on Assets-88.84% Debt Debt-to-Equity RatioN/A Current Ratio1.97 Quick Ratio1.97 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$2.34 per share Price / Book2.32Miscellaneous Outstanding Shares3,220,000Free Float2,412,000Market Cap$17.45 million OptionableNot Optionable Beta0.86 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesDr. Pardeep Nijhawan FRCPC (Age 53)M.D., CEO, Company Secretary & Director Comp: $475.33kDr. Michael J. Brooks M.B.A. (Age 46)Ph.D., President Comp: $439.27kMr. Stephen L. Lemieux BA (Age 47)CPA, CA, CPA, MMPA, Chief Financial Officer Comp: $402.86kKey CompetitorsOncternal TherapeuticsNASDAQ:ONCTProteostasis TherapeuticsNASDAQ:PTIAnebulo PharmaceuticalsNASDAQ:ANEBHookipa PharmaNASDAQ:HOOKProPhase LabsNASDAQ:PRPHView All CompetitorsInsidersPardeep NijhawanBought 5,000 shares on 3/25/2024Total: $20,000.00 ($4.00/share)View All Insider Transactions EDSA Stock Analysis - Frequently Asked Questions How have EDSA shares performed this year? Edesa Biotech's stock was trading at $4.57 on January 1st, 2024. Since then, EDSA stock has increased by 18.6% and is now trading at $5.42. View the best growth stocks for 2024 here. How were Edesa Biotech's earnings last quarter? Edesa Biotech, Inc. (NASDAQ:EDSA) posted its earnings results on Friday, May, 10th. The company reported ($0.58) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.69) by $0.11. When did Edesa Biotech's stock split? Edesa Biotech shares reverse split on the morning of Wednesday, October 11th 2023. The 1-7 reverse split was announced on Tuesday, October 10th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, October 10th 2023. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split. How do I buy shares of Edesa Biotech? Shares of EDSA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Edesa Biotech own? Based on aggregate information from My MarketBeat watchlists, some other companies that Edesa Biotech investors own include Pfizer (PFE), AbbVie (ABBV), VBI Vaccines (VBIV), Vaxart (VXRT), Exxon Mobil (XOM), Anavex Life Sciences (AVXL) and Occidental Petroleum (OXY). This page (NASDAQ:EDSA) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredThe asset beating inflation by 4xCentral Bank Gold Heist In Progress Central banks are buying gold at record rates... and billionaire invest...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edesa Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Edesa Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.